Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWTG.L Regulatory News (WTG)

  • There is currently no data for WTG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Further Investment in NARS

27 Sep 2013 15:25

RNS Number : 1555P
Quindell Portfolio PLC
27 September 2013
 



For immediate release

Quindell Portfolio Plc

("Quindell" or the "Group") 

 

Further Investment in Nationwide Accident Repair Services plc

 

Quindell Portfolio Plc (AIM: QPP.L), the provider of sector leading expertise in software, consultancy and technology enabled outsourcing in its key markets, being Insurance, Telecommunications and their related sectors is pleased to announce that the Company has acquired further shares in Nationwide Accident Repair Services plc (AIM:NARS.L) ("NARS"), the largest dedicated provider of accident repair services in the UK, increasing its shareholding by 2.8% to 25.3%.

 

1,230,000 shares, representing approximately 2.8% of the issued share capital of NARS were acquired on 27 September 2013 from the shareholder listed in the table below in exchange for the issue by Quindell of 6,359,100 new Ordinary Shares of 1 penny each in the Company, a ratio of 5.17 new Quindell shares for each NARS share.

 

NARS

Shareholder

Shareholding

pre- investment

 

Shares sold to Quindell

 

Shareholding post investment

%

Number

%

Number

%

3G Capital Management LLC

2.8

1,230,000

2.8

-

-

Previously acquired:

Miton Group (note 1)

14.5

6,261,000

14.5

-

-

Octopus Investments Nominees Limited

8.0

3,439,423

8.0

-

-

Total

25.3

10,930,423

25.3

-

-

 

Note 1: As investment manager subject to necessary consents

At the closing mid market price on 26 September 2013 for Quindell shares of 16.5 pence, the share exchange values each ordinary share in NARS at 85.3 pence, representing a 34.3% premium on the closing mid market price of 63.5 pence per NARS share on the same date, or a 31.4% premium on the average closing mid market price of 64.9 pence per NARS share over the last six months.

 

Application has been made for 6,359,100 shares to be admitted to trading on AIM. Admission of the shares is expected to occur on 3 October 2013. Following Admission, Quindell will have 4,314,651,747 ordinary shares in issue. The Company has no ordinary shares held in treasury. The total of 4,314,314,747 ordinary shares may therefore be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

 

Rob Terry, Founder and Executive Chairman of Quindell said: "We are pleased to be announcing this increase to our shareholding, taking it to 25.3% which is clearly a key level of influence to have reached in relation to any future shareholder decisions regarding the business, and we will continue to look at building our holding to 29.9%.

 

As previously stated, having a direct ownership stake in a repair services networks will enable us to take advantage of the volume we manage for our clients. Following an initial meeting with the Chief Executive and Finance Director of NARS yesterday we remain extremely confident of the value creation opportunity for both NARS' and Quindell's shareholders by the two companies working in collaboration in the market even though no specific agreements have been reached at this stage."

 

 

For further information:

Quindell Portfolio PlcRob Terry, Founder and Executive Chairman

 

Laurence Moorse, Group Finance Director

 

Ian Farrelly, Group General Counsel & Company Secretary

Head of Investor Relations

Tel: 01489 864201

terryr@quindell.com

Tel: 01489 864205

moorsel@quindell.com

Tel: 01489 864217

farrellyi@quindell.com

 

Cenkos Securities plcJoint Broker and Nominated AdvisorStephen Keys (Corporate Finance)

 

Canaccord Genuity Limited

Joint Broker and Financial Advisor

Simon Bridges

Bruce Garrow

 

 

Tel: 020 7397 8900

 

 

Tel: 020 7523 8350

 

 

 

Media EnquiriesRedleaf Polhill Limited

Rebecca Sanders-Hewett

Jenny Bahr

 

Tel: 020 7382 4730

quindell@redleafpr.com

 

Notes to Editors: About Quindell Portfolio Plc

Quindell Portfolio Plc is a provider of sector leading expertise in Software, Consulting and Technology Enabled Outsourcing in its key markets being Insurance, Telecommunications and their Related Sectors. Quindell enters the second half of 2013 with a run rate of gross sales of more than £350 million and with approaching £50 million of EBITDA earned in the first half of 2013. Our award winning Business Transformational, Software, Consulting and Outsourcing Solutions are recognised as delivering significant savings and additional sales to our customers every year.

For further information, please visit www.quindell.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFLSAVIDFIV
Date   Source Headline
10th Feb 20207:00 amRNSPre-close update
7th Feb 20207:00 amRNSCompletion of the sale of Healthcare Services
3rd Feb 20207:00 amRNSUpdate re the sale of Healthcare services business
23rd Jan 20207:00 amRNSChange of Auditor
10th Jan 20204:40 pmRNSSecond Price Monitoring Extn
10th Jan 20204:35 pmRNSPrice Monitoring Extension
8th Jan 202011:09 amRNSHolding(s) in Company
8th Jan 202010:47 amRNSHolding(s) in Company
31st Dec 20198:00 amRNSUpdate re the sale of Healthcare services business
23rd Dec 201912:03 pmRNSHolding(s) in Company
17th Dec 20192:22 pmRNSHolding(s) in Company
29th Nov 20197:00 amRNSUpdate re the sale of Healthcare services business
22nd Oct 20194:10 pmRNSHolding(s) in Company
22nd Oct 20194:10 pmRNSHolding(s) in Company
21st Oct 20197:00 amRNSSettlement with Slater & Gordon (UK) 1 Limited
16th Oct 20194:37 pmRNSSettlement with Mr Robert Terry and others
17th Sep 20197:00 amRNSSale of Healthcare Services
4th Sep 20197:00 amRNSHalf-year Report
29th Aug 20197:03 amRNSCounterclaim against Slater & Gordon (UK) 1 Ltd
31st Jul 20197:00 amRNSAppointment of Nominated Adviser and Broker
5th Jul 20195:04 pmRNSHolding(s) in Company
1st Jul 20197:00 amRNSDirectorate Change
26th Jun 20192:14 pmRNSResult of AGM
13th Jun 20197:00 amRNSProposed counterclaim by Robert Terry and others
6th Jun 201910:23 amRNSHolding(s) in Company
3rd Jun 20197:00 amRNSAnnual Financial Report
9th May 20197:00 amRNSFinal Results
4th Apr 20191:32 pmRNSHolding(s) in Company
3rd Apr 201910:24 amRNSHolding(s) in Company
28th Mar 201910:25 amRNSHolding(s) in Company
12th Feb 20194:14 pmRNSHolding(s) in Company
31st Jan 20197:00 amRNSPre-close trading update
24th Dec 20187:00 amRNSHolding(s) in Company
3rd Dec 20182:31 pmRNSHolding(s) in Company
6th Nov 20184:57 pmRNSHolding(s) in Company
11th Oct 20183:33 pmRNSHolding(s) in Company
9th Oct 20185:20 pmRNSHolding(s) in Company
25th Sep 20185:50 pmRNSHolding(s) in Company
13th Sep 20187:00 amRNSHolding(s) in Company
30th Aug 20187:00 amRNSHalf-year Report
23rd Aug 201810:39 amRNSHolding(s) in Company
2nd Aug 20182:20 pmRNSHolding(s) in Company
29th Jun 201810:35 amRNSHolding(s) in Company
27th Jun 201811:55 amRNSAGM Results
17th May 20187:34 amRNSAnnual Financial Report
1st May 201812:27 pmRNSHolding(s) in Company
27th Apr 20187:00 amRNSFinal Results
13th Apr 20184:21 pmRNSHolding(s) in Company
16th Mar 201810:40 amRNSHolding(s) in Company
20th Feb 20187:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.